Skip to main content

Wingrove Theresa's Form 4 filing

ImmunoGen, Inc. (IMGN) · filed Sep 19, 2023

Accession no.
0001415889-23-013428
Filed
Sep 19, 2023
Trade date
Sep 15, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.96M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Wingrove TheresaCIK 0001510720Officer (SVP OF REGULATORY AFFAIRS)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 15, 2023Common StockMOption exerciseAcquired+50,000$4.55+$227,500136,156Direct
Sep 15, 2023Common StockMOption exerciseAcquired+33,334$3.05+$101,668.7169,490Direct
Sep 15, 2023Common StockMOption exerciseAcquired+25,334$2.68+$67,895.12194,824Direct
Sep 15, 2023Common StockSSaleDisposed−192,013$15.44−$2,964,680.722,811Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 15, 2023Common StockMOption exerciseDisposed−50,000$0.00$0241,769Direct
Sep 15, 2023Common StockMOption exerciseDisposed−33,334$0.00$016,666Direct
Sep 15, 2023Common StockMOption exerciseDisposed−25,334$0.00$012,666Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)